切换至 "中华医学电子期刊资源库"

中华消化病与影像杂志(电子版) ›› 2023, Vol. 13 ›› Issue (06) : 373 -377. doi: 10.3877/cma.j.issn.2095-2015.2023.06.002

论著

HHLA2过表达胃癌细胞株构建及细胞功能的初步研究
韩晓娟, 徐佳倩, 朱玉兰, 王莹, 李源, 冯珺, 邵东()   
  1. 213003 江苏常州,苏州大学附属第三医院消化内科
    213003 江苏常州,苏州大学附属第三医院肿瘤科
    213003 江苏常州,苏州大学附属第三医院肿瘤生物诊疗中心
  • 收稿日期:2023-05-18 出版日期:2023-12-01
  • 通信作者: 邵东
  • 基金资助:
    常州市应用基础研究计划(CJ20210074); 常州市卫生健康委青年人才科技项目(QN202015)

Construction and cell function study of HHLA2-overexpressing gastric cancer cells

Xiaojuan Han, Jiaqian Xu, Yulan Zhu, Ying Wang, Yuan Li, Jun Feng, Dong Shao()   

  1. Department of Gastroenterology, the Third Affiliated Hospital of Soochow University, Changzhou 213003, China
    Department of Oncology, the Third Affiliated Hospital of Soochow University, Changzhou 213003, China
    Cancer Biological Diagnosis and Treatment Center, the Third Affiliated Hospital of Soochow University, Changzhou 213003, China
  • Received:2023-05-18 Published:2023-12-01
  • Corresponding author: Dong Shao
引用本文:

韩晓娟, 徐佳倩, 朱玉兰, 王莹, 李源, 冯珺, 邵东. HHLA2过表达胃癌细胞株构建及细胞功能的初步研究[J/OL]. 中华消化病与影像杂志(电子版), 2023, 13(06): 373-377.

Xiaojuan Han, Jiaqian Xu, Yulan Zhu, Ying Wang, Yuan Li, Jun Feng, Dong Shao. Construction and cell function study of HHLA2-overexpressing gastric cancer cells[J/OL]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 373-377.

目的

使用慢病毒载体构建稳定过表达人内源性逆转录病毒H-长末端重复关联蛋白2(HHLA2)的胃癌细胞系,探讨细胞发生的生物学功能改变。

方法

由目的基因以及Lipo2000转染试剂构建重组质粒,将该质粒转染293T细胞,浓缩其细胞上清液并测定浓度,再将浓缩液转染胃癌细胞株BGC-823和MGC80-3,利用流式细胞术分选并验证GFP+稳定过表达的细胞株。开展细胞功能实验(含迁移试验和增殖试验等)以分析过表达HHLA2胃癌细胞株的生物学功能。

结果

酶切及测序结果示,重组慢病毒载体成功构建。流式分选及验证示,HHLA2过表达胃癌稳转株。过表达HHLA2可使胃癌细胞株MGC80-3和BGC-823加快增殖,其24 h、48 h、72 h吸光度值均较对照细胞株升高(P<0.05)。过表达HHLA2可增强胃癌细胞株BGC-823的迁移能力,其24 h、48 h迁移率均较对照细胞株升高(P<0.05);MGC80-3细胞迁移距离未明显变长(P>0.05)。

结论

HHLA2过表达能够提高胃癌细胞的增殖和迁移能力。

Objective

To construct gastric cancer cell lines overexpressing human endogenous retrovirus subfamily H long terminal repeat associating protein 2(HHLA2)by lentivirus vector and verify their biological functions.

Methods

The target gene and Lipo2000 reagent were used to construct recombinant plasmid, which was then applied to transfect 293T cell.We collect The cell supernatant was concentrated and the concentration was determined.The concentrated liquid was then transfected into gastric cancer cell lines BGC-823 and MGC80-3.The flow cytometry was used to sort and verify the GFP+ stable overexpressing cell lines.Cell function experiments(including migration experiment and proliferation experiment)were applied to explore the biological functions of overexpressing HHLA2 gastric cancer cell lines.

Results

The results of restriction enzyme digestion and sequencing showed that the recombinant lentivirus vector was successfully constructed.Flow sorting and verification showed that HHLA2 overexpressed gastric cancer stably transformed strains.Overexpression of HHLA2 could accelerate the proliferation of gastric cancer cell lines MGC80-3 and BGC-823, and their absorbance values at 24 h, 48 h and 72 h were higher than those of the control cell lines(P<0.05). Overexpression of HHLA2 could enhance the migration ability of gastric cancer cell line BGC-823, and its migration rate at 24 h and 48 h was higher than that of the control cell line(P<0.05). However, the migration distance of MGC80-3 cells did not increase significantly(P>0.05).

Conclusion

Overexpression of HHLA2 can promote the proliferation and migration ability of gastric cancer.

图1 质粒转染293T细胞
图2 过表达HHLA2慢病毒载体图片
图3 过表达HHLA2胃癌细胞株GFP荧光图片
图4 过表达HHLA2对胃癌细胞株增殖能力的影响注:*P<0.05,**P<0.01,***P<0.001,****P<0.0001
图5 过表达HHLA2对胃癌细胞株迁移能力的影响
图6 过表达HHLA2对胃癌细胞株迁移能力的影响
1
Bolandi NDerakhshani AHemmat N,et al.The Positive and Negative Immunoregulatory Role of B7 Family:Promising Novel Targets in Gastric Cancer Treatment[J].Int J Mol Sci202122(19):10719.
2
Janakiram MChinai JMFineberg S,et al.Expression,Clinical Significance,and Receptor Identification of the Newest B7 Family Member HHLA2 Protein[J].Clin Cancer Res201521(10):2359-2366.
3
Wei LTang LChang H,et al.HHLA2 overexpression is a novel biomarker of malignant status and poor prognosis in gastric cancer[J].Hum Cell202033(1):116-122.
4
Shimonosono MArigami TYanagita S,et al.The association of human endogenous retrovirus-H long terminal repeat-associating protein 2(HHLA2)expression with gastric cancer prognosis[J].Oncotarget20189(31):22069-22078.
5
曹维维,袁成良.人类白细胞抗原-G5过表达慢病毒R-HLA-G5稳转细胞株的建立[J].中国临床药理学杂志202137(4):2495-2498.
6
Sung HFerlay JSiegel RL,et al.Global Cancer Statistics 2020:GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J].CA Cancer J Clin202171(3):209-249.
7
Rieder SAWang JWhite N,et al.B7-H7(HHLA2)inhibits T-cell activation and proliferation in the presence of TCR and CD28 signaling[J].Cell Mol Immunol202118(6):1503-1511.
8
Cheng HBorczuk AJanakiram M,et al.Wide Expression and Significance of Alternative Immune Checkpoint Molecules,B7x and HHLA2,in PD-L1-Negative Human Lung Cancers[J].Clin Cancer Res201824(8):1954-1964.
9
Xiao YLi HYang L,et al.The Expression Patterns and Associated Clinical Parameters of Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 and Transmembrane and Immunoglobulin Domain Containing 2 in Oral Squamous Cell Carcinoma[J].2019,2019 5421985.
10
Xu YHuang ZYu X,et al.HHLA2 Expression is Associated with Poor Survival in Patients with Hepatocellular Carcinoma[J].Biologics2021,15 329-341.
11
Chen LZhu DFeng J,et al.Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients[J].Cancer Cell Int201919:101.
12
Zhou QHLi KWChen X,et al.HHLA2 and PD-L1 co-expression predicts poor prognosis in patients with clear cell renal cell carcinoma[J].J Immunother Cancer20208(1):e000157.
13
Boor PPCSideras KBiermann K,et al.HHLA2 is expressed in pancreatic and ampullary cancers and increased expression is associated with better post-surgical prognosis[J].Br J Cancer2020122(8):1211-1218.
14
Janakiram MChinai JMZhao A,et al.HHLA2 and TMIGD2:new immunotherapeutic targets of the B7 and CD28 families[J].Oncoimmunology20154(8):e1026534.
15
Bhatt RSBerjis AKonge JC,et al.KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1[J].Cancer Immunol Res20219(2):156-169.
16
Sun WLi STang G,et al.HHLA2 deficiency inhibits non-small cell lung cancer progression and THP-1 macrophage M2 polarization[J].Cancer Med202110(15):5256-5269.
[1] 沈华娟, 庄剑波, 刘春. 幽门螺杆菌感染抗体分型与胃黏膜炎性病变程度及黏膜组织学变化间的相关性[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(03): 156-162.
[2] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[3] 黄一博, 李至彦, 林晨, 陶亮, 王萌, 管文贤. 胃癌根治术中淋巴结示踪剂的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 586-588.
[4] 丁关棣, 黄云, 曹震, 刘刚. 胃癌根治术后感染性并发症预测:基于真实世界数据的Nomogram模型开发与验证[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(03): 261-266.
[5] 王鹏, 邵欣欣, 胡海涛, 田艳涛, 钟宇新. 改良MOBS 吻合法在全腹腔镜近端胃大部分切除中的应用[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(05): 267-270.
[6] 胡海涛, 邵欣欣, 姜玉娟, 王鹏, 李维坤, 卢一鸣, 田艳涛. 十二指肠残端处理对全腹腔镜胃癌根治术后并发症的影响[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(04): 205-209.
[7] 王泽钦, 洪军, 王雅平, 王健, 蒿汉坤. W型肝脏悬吊技术在全腹腔镜下全胃切除术中的应用[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(04): 218-221.
[8] 刘先勇, 秦东梅, 张若梅, 李俊娇, 孟春芹, 邬明歆, 王玉红, 赵新鲜, 徐瑞联, 洪文文, 马玲, 仇玮, 周宇. Her2/Hes1在肠型胃癌Correa级联反应3个病理阶段中的表达及意义[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 321-327.
[9] 李晶, 潘侠, 周芳, 汪晶, 洪佳. 普鲁卡因通过上调lncRNA DGCR5抑制胃癌细胞增殖、迁移和侵袭[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(03): 151-158.
[10] 甘曦, 廖鑫. 胃癌旁肿瘤沉积与CT影像学特征、血清指标及病理特征的关联性分析[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 422-425.
[11] 苑乐添, 王艺霖, 沈子剑, 闫呈新. 血清GDF15、sB7-H1联合多层螺旋CT灌注成像技术对胃癌患者淋巴结转移的诊断价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(01): 62-66.
[12] 葛雪梅. SOX与mFOLFOX6化疗方案对晚期胃癌的疗效与安全性[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(01): 67-71.
[13] 郭彬焰, 褚衍六. 胃癌分期评估模型的研究现状与展望[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(02): 120-122.
[14] 张其德. 内镜下精准肌层剥离术在伴有黏膜下层纤维化/疤痕的早期胃癌治疗的作用初探(视频)[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(02): 144-144.
[15] 胡陈玥, 葛贤秀, 邓雪婷, 姚家楠, 缪林. 图像增强放大内镜诊断胃癌前病变及早期胃癌[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(01): 47-51.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?